Unknown

Dataset Information

Human tissue kallikrein in the treatment of acute ischemic stroke.


ABSTRACT: Acute ischemic stroke (AIS) remains a major cause of death and disability throughout the world. The most severe form of stroke results from large vessel occlusion of the major branches of the Circle of Willis. The treatment strategies currently available in western countries for large vessel occlusion involve rapid restoration of blood flow through removal of the offending blood clot using mechanical or pharmacological means (e.g. tissue plasma activator; tPA). This review assesses prospects for a novel pharmacological approach to enhance the availability of the natural enzyme tissue kallikrein (KLK1), an important regulator of local blood flow. KLK1 is responsible for the generation of kinins (bradykinin and kallidin), which promote local vasodilation and long-term vascularization. Moreov

SUBMITTER: Alexander-Curtis M 

PROVIDER: S-EPMC6348491 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature